Share tips

If only you’d invested in: Marshalls

Marshalls makes concrete and stone paving for retail outlets and the construction industry, operating throughout the UK. Business has held up well despite the Brexit uncertainty.

Contrarian picks that promise big profits

Alec Cutler of Orbis Global Balanced Fund finds three stocks ripe with opportunity.

Debenhams is the latest retailer to go down

The group fell into administration this week, marking another setback for Sports Direct founder Mike Ashley. Matthew Partridge reports.

Share tips of the week

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK’s financial pages.

The drugs don’t work: stopping the spread of the superbugs

Antibiotic resistance could turn medical inconveniences into death sentences and become a bigger killer than cancer. Governments and pharmaceutical companies are fighting back. Sarah Moore reports.

Three stocks that will stand up to political pressure

Professional investor Andy Headley of Alliance Trust and Veritas Asset Management chooses three of his favourite stocks.

Is Saga’s massive profit warning a buying opportunity?

Saga, the company that offers products to the over-50s, has seen its shares hit a record low after a massive profit warning. So is it a bargain buy, asks John Stepek,or one to leave well alone?

Share tips of the week

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK’s financial pages.

British stocks are due a bounce

Uncertainty over Brexit has prompted consumers and companies to put off investing in British stocks. Once clarity returns, cheap stocks should rebound, says David Stevenson.

Immunotherapy: new hope in the battle against cancer

Immunotherapy is a burgeoning sector that heralds a breakthrough against the world’s second-most deadly disease. Dr Mike Tubbs explains how investors can benefit too.

Alexion: a rare opportunity in biotech

Alexion focuses on diseases that affect only a tiny proportion of the population – a lucrative niche.

Herald: a tried and tested investment trust

Institutional investors keep their distance, but Katie Potts, manager of the Herald Investment Trust, is clearly doing something right.

Showing page 5 of 344